Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Dermatology

Clinical Pharmacology

Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acne

Journal of the European Academy of Dermatology and Venereology | Aug 26, 2019 Clinical Pharmacology

Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): A randomized, double-blind, active-comparator-controlled phase 3 trial

The Lancet | Aug 22, 2019 Clinical Pharmacology

Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma

New England Journal of Medicine | Aug 21, 2019 Clinical Pharmacology

Long-term clinical outcomes of imiquimod 5% cream vs diclofenac 3% gel for actinic keratosis on the face or scalp: A pooled analysis of two randomized controlled trials

Journal of the European Academy of Dermatology and Venereology | Aug 20, 2019 Clinical Pharmacology

Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: Results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS)

British Journal of Dermatology | Aug 19, 2019 Clinical Pharmacology

Axitinib in combination with toripalimab, a humanized immunoglobulin G4 monoclonal antibody against programmed cell death-1, in patients with metastatic mucosal melanoma: An open-label phase IB trial

Journal of Clinical Oncology | Aug 16, 2019 Clinical Pharmacology

A brief communication on circulating PD-1-positive T-regulatory lymphocytes in melanoma patients undergoing adjuvant immunotherapy with nivolumab

Journal of Immunotherapy | Aug 16, 2019 Clinical Pharmacology

Guselkumab vs secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): Results from a phase 3, randomized controlled trial

The Lancet | Aug 15, 2019 Clinical Pharmacology

Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study

International Journal of Cancer | Aug 15, 2019 Clinical Pharmacology

Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti–PD-1 in patients with metastatic melanoma

Cancer | Aug 15, 2019 Clinical Pharmacology

« Prev 1 … 49 50 51 52 53 … 92 Next »

Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acne

Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): A randomized, double-blind, active-comparator-controlled phase 3 trial

Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma

Long-term clinical outcomes of imiquimod 5% cream vs diclofenac 3% gel for actinic keratosis on the face or scalp: A pooled analysis of two randomized controlled trials

Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: Results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS)

Axitinib in combination with toripalimab, a humanized immunoglobulin G4 monoclonal antibody against programmed cell death-1, in patients with metastatic mucosal melanoma: An open-label phase IB trial

A brief communication on circulating PD-1-positive T-regulatory lymphocytes in melanoma patients undergoing adjuvant immunotherapy with nivolumab

Guselkumab vs secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): Results from a phase 3, randomized controlled trial

Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study

Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti–PD-1 in patients with metastatic melanoma

Article on Hypertension in CKD Patients: Management Updates

Artice: Adult Vaccination Updates Every Family Doctor Should Know

MD Clip on Diabetes and Urinary ACR with Dr Saraogi

Article: TSH Abnormalities and Treatment Algorithms in Primary Care

New research aims to transform treatments of aggressive blood cancer

Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acne

Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): A randomized, double-blind, active-comparator-controlled phase 3 trial

Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma

Long-term clinical outcomes of imiquimod 5% cream vs diclofenac 3% gel for actinic keratosis on the face or scalp: A pooled analysis of two randomized controlled trials

Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: Results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS)

Axitinib in combination with toripalimab, a humanized immunoglobulin G4 monoclonal antibody against programmed cell death-1, in patients with metastatic mucosal melanoma: An open-label phase IB trial

A brief communication on circulating PD-1-positive T-regulatory lymphocytes in melanoma patients undergoing adjuvant immunotherapy with nivolumab

Guselkumab vs secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): Results from a phase 3, randomized controlled trial

Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study

Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti–PD-1 in patients with metastatic melanoma

Article on Hypertension in CKD Patients: Management Updates

Artice: Adult Vaccination Updates Every Family Doctor Should Know

MD Clip on Diabetes and Urinary ACR with Dr Saraogi

Article: TSH Abnormalities and Treatment Algorithms in Primary Care

New research aims to transform treatments of aggressive blood cancer

Select Specialty

Select Topic